Dexcom Inc

DXCM

Dexcom Inc

@DanielH
1 year ago

Understand The Balance Sheet

Understand The Balance Sheet

Overall seems healthy, the only thing I find noteworthy is the shareholder's equity which has remained positive and growing (only shrink slightly in 2023)

  • Operating Expenses compared to Cash

    • They have approximately 4 months of operating expenses in cash

      • Annual Operating Expenses: $1,838,200,000

      • Cash: $606,100,000

  • Would be able to pay off long-term debt in approximately 2 years

    • Long-term debt: $1,237,000,000

    • FCF: $630,700,000

  • Total assets: $6,484,500,000

    • Goodwill: $22,800,000

    • Intangibles, net: $103,400,000

  • Total liabilities: $4,381,900,000

  • Current ratio: 1.47

    • Current assets: $4,301,400

    • Current liabilities: $2,932,000

  • Shareholders equity

    • With the exception of 2023 (shrank by 2.96%), has been growing, but not 10%

    • Growth rates:

      • 9 year: 28.43%

      • 5 year: 18.96%

      • 1 year: 1.64%